Microba Life Sciences Ltd: Amended Constitution
Microba Life Sciences Ltd: Results of Annual General Meeting
Microba Life Sciences Ltd: 2024 Annual General Meeting Presentation
Microba Life Sciences Ltd: Chair, Deputy Chair and CEO Addresses to AGM
Microba Life Sciences Ltd: Trading Update
Microba Life Sciences Ltd: Change of Director's Interest Notice - Pasquale Rombola
Microba Life Sciences Ltd: Change of Director's Interest Notice - Prof Ian Frazer
Microba Life Sciences Ltd: Bell Potter Healthcare Conference Presentation
Microba Life Sciences Ltd: Microba receives $6 million R&D Tax Incentive Refund
Microba Life Sciences Ltd: Release of Securities from Voluntary Escrow
Microba Life Sciences Ltd: Q1 FY25 Quarterly Activities Report & Appendix 4C
Microba Life Sciences Ltd: Q1 FY25 Quarterly Investor Presentation
Microba Life Sciences Ltd: Annual Report to Shareholders
Microba Life Sciences Ltd: Letter to Shareholders, Notice of AGM & Proxy Form
Microba Life Sciences Ltd: Details of Q1 FY25 Quarterly Report, Appendix 4C & Webinar
Microba Life Sciences Ltd: Strategic transfer of Microba Research Services Unit to CMC
Microba Life Sciences Ltd: Date of AGM and Closing Date for Director Nominations
Microba Life Sciences Ltd: Microba Presents at ASX Small & Mid Cap Conference
Microba Life Sciences Ltd: Change of Joint Company Secretary Role
Microba Life Sciences Ltd: 2024 Annual Report & Appendix 4E
No Data